NetScientific PLC is a life sciences and sustainability technology investment and commercialisation group
We leverage trans-Atlantic relationships and global opportunities to deliver shareholder value.
We look to maximise shareholder returns through focused execution of our investment strategy with current portfolio companies, and targeted investments in existing and new investment opportunities.
NetScientific develops a customized investment and realisation strategy for its portfolio companies.
We seek to enable the companies we work to access the right type of funding, proactive management support and resources specific to their sector, stage of development and available opportunities.
NetScientific is a holding company of its various technology businesses. It is not an AIM Investing Company

Our Subsidiaries and Portfolio

A Focus on Life Sciences, Technology, and Sustainability

Board and Management

Sector-specialist senior management team with extensive commercial experience.

Dr Ilian Iliev

Chief Executive Officer

John Clarkson

Executive Chairman

Clive Sparrow

Non-Executive Director

Professor Stephen Smith

Non-Executive Director

Stephen Crowe

Chief Financial Officer


NetScientific plc ("NetScientific", the “Group” or the "Company")   PDS COVID-19 Vaccine Commercialisation Update   Blanver joins PDS-Farmacore COVID-19 Vaccine Consortium   PDS Biotech and Farmacore Announce Blanver…
NetScientific plc ("NetScientific" or the "Company") ProAxsis Update London, UK – 22 February 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group,…
NetScientific plc ("NetScientific" or the "Company")   PDS Biotech Announces Preliminary Efficacy Achievement in Phase II Combination Trial of PDS0101 Led by the National Cancer Institute   Restoration…
NetScientific PLC: Life Sciences & Technology Investments